PRESS RELEASE
News
-
-
PRESS RELEASE
Custodian Property Income REIT plc: Third quarter trading update shows rental growth supporting fully covered dividends
Custodian Property Income REIT plc provides third quarter trading update showing rental growth supporting fully covered dividends. Leasing activity, passing rent, like-for-like ERV, valuations, NAV, and investment manager's commentary detailed -
-
PRESS RELEASE
Woodside Energy Group Ltd Concludes Discussions with Santos
Woodside, a global energy company, has ceased discussions regarding a potential merger with Santos Ltd. CEO Meg O'Neill emphasizes value accretive transactions and highlights the potential for value creation in the global LNG sector -
PRESS RELEASE
Holcim acquires ZinCo to advance green roofing systems
Holcim acquires ZinCo, a leader in advanced green roofing systems, to expand its sustainable building solutions and bring more nature into cities. The acquisition will advance Holcim's range of sustainable roofing systems, including green and solar roofing, and its overall mission to lead the transition to sustainable building. ZinCo provides tailored solutions for urban wellbeing, including reducing heat island effects and improving air quality -
PRESS RELEASE
Marinomed Biotech AG with important progress for Carragelose in 2024
Marinomed Biotech AG enrolls first patient in clinical study for Carragelose eye drops and receives patents in Singapore, South Korea, and Brazil, strengthening its IP portfolio. The company plans to launch Carragelose eye drops and nasal spray in 2024, targeting allergy and eye care markets -
PRESS RELEASE
EQS-Adhoc: CTS EVENTIM: Dynamic growth across all business segments produces record results for 2023
CTS EVENTIM AG & Co. KGaA achieved a record revenue of EUR 2.359 billion in 2023, representing a 22.5% increase year-on-year. Both Ticketing and Live Entertainment segments drove the growth, with a 32.5% increase in Ticketing segment revenue and a 18.9% increase in Live Entertainment segment revenue -
PRESS RELEASE
Just – Evotec Biologics expands development and manufacturing agreement with ABL for broadly neutralising antibodies against HIV
Evotec SE expands partnership with ABL to develop and manufacture broadly neutralising antibodies against HIV, funded by NIAID. The collaboration aims to supply clinical material for ongoing global trials -
PRESS RELEASE
voestalpine AG: Economic slowdown impacts voestalpine earnings for Q3 2023/24
voestalpine AG's Q3 2023/24 earnings impacted by economic slowdown, with revenue at EUR 12.4 billion (-8.8%), EBITDA at EUR 1.3 billion (-31.7%). CEO highlights global positioning and industry diversification -
PRESS RELEASE
Hannover Re confirms guidance for 2024 on the back of further improvements in terms and conditions and sustained attractive prices
Hannover Re confirms guidance for 2024 on the back of further improvements in terms and conditions and sustained attractive prices. The company anticipates Group net income of at least EUR 2.1 billion for the 2024 financial year
